Skye Bioscience (SKYE)
US Market

Skye Bioscience (SKYE) Cash flow


Skye Bioscience Cash Flow

SKYE's free cash flow for Q was $-4.06M. For the fiscal year, SKYE's free cash flow was decreased by $6.57M and operating cash flow was $-4.05M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -10.11M$ 4.57K$ -6.47M$ -6.05M$ -6.03M$ -3.94M
Investing Cash Flow
$ 6.60M$ 5.21M$ -90.87K$ -7.23K$ 0.00$ -4.38K
Financing Cash Flow
$ 16.47M$ -208.79K$ 13.08M$ 6.70M$ 6.00M$ 5.54M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 48.29M$ 8.99M$ 8.99M$ 2.47M$ 1.83M$ 1.86M
Income Tax Paid Supplemental Data
$ 3.60K$ 6.74K$ 1.60K$ 1.60K$ 1.60K$ 1.64K
Interest Paid Supplemental Data
$ 135.92K$ 333.55K$ 44.09K$ 117.46K$ 371.42K$ 23.33K
Issuance Of Capital Stock
--$ 6.06M$ 6.09M$ 1.92M$ 3.10M
Issuance Of Debt
$ 1.15M$ -210.76K-$ 566.70K$ 3.99M$ 2.35M
Repayment Of Debt
$ -236.68K$ -891.66K--$ -3.99M$ 0.00
Free Cash Flow
$ -4.58M$ 4.57K$ -6.57M$ -6.06M$ -6.03M$ -3.95M
Domestic Sales
Foreign Sales
Currency in USD

Skye Bioscience Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis